Exponent Surpasses €1 Billion Target with Fund V

Funding | Jul 09, 2025 | Exponent Private Equity

Exponent Surpasses €1 Billion Target with Fund V

Exponent Private Equity, a prominent European private equity firm, announced the final close of its fifth fund, surpassing its target by 20% with commitments totaling over €1 billion. The Fund attracted strong backing from an international array of investors, including pension funds, endowments, and sovereign wealth funds. Exponent's strategy focuses on mid-market businesses across the UK, Ireland, and the Benelux, primarily investing in corporate, family, and founder-owned enterprises with the potential for profit doubling through revenue-driven growth. Exponent's Fund V has already made investments in Chanelle Pharma, Ethos Engineering, Kingsbridge Healthcare Group, and Hippo Digital, reinforcing their position as a trusted partner in the mid-market sector. The firm was aided in the fundraising process by Rede Partners LLP and Debevoise & Plimpton LLP.

Sectors

  • Private Equity
  • Pharmaceuticals
  • Healthcare
  • Technology
  • Engineering and Construction

Geography

  • Europe – Exponent Private Equity operates in the UK, Ireland, and Benelux, and the fund attracted European investors.
  • North America – Fund V garnered investment interest from North American entities.
  • Middle East – The fund received commitments from Middle Eastern investors.
  • Asia – Asian investors are part of the globally diversified base supporting Fund V.
  • Ireland – Investments in companies like Kingsbridge Healthcare Group and Ethos Engineering, with operations in Ireland, highlight regional relevance.

Industry

  • Private Equity – Exponent Private Equity is involved, focusing primarily on mid-market businesses, showcasing activity in the private equity industry.
  • Pharmaceuticals – Involvement through Exponent's investment in Chanelle Pharma, a European leader in generic and veterinary pharmaceuticals.
  • Healthcare – Participation through Exponent's investment in Kingsbridge Healthcare Group, Northern Ireland's largest private healthcare provider.
  • Technology – Related through Exponent's investment in Hippo Digital, a technology consultancy specializing in digital transformation.
  • Engineering and Construction – Ethos Engineering, specializing in sustainable data centre design, represents Exponent's investment in the engineering sector.

Financials

  • €1 billion – Total commitments raised for Fund V, exceeding the target.
  • 20% – Percentage by which Fund V surpassed its fundraising target.

Participants

NameRoleTypeDescription
Exponent Private EquityPrivate Equity FirmCompanyA leading European private equity firm behind Fund V.
Marius ØstliePartnerPersonPartner at Exponent, responsible for commenting on the fund raise.
Richard LenaneManaging PartnerPersonManaging Partner at Exponent, speaking on the differentiated strategy.
Rede Partners LLPFundraising AdvisorCompanyAdvised Exponent on the fundraise.
Debevoise & Plimpton LLPLegal CounselCompanyServed as legal counsel for Exponent's fundraising.
Chanelle PharmaPortfolio CompanyCompanyA European leader in generic and veterinary pharmaceuticals.
Ethos EngineeringPortfolio CompanyCompanySpecialist in sustainable, mission-critical data centre design.
Kingsbridge Healthcare GroupPortfolio CompanyCompanyThe largest private healthcare provider in Northern Ireland.
Hippo DigitalPortfolio CompanyCompanyTechnology consultancy focused on user-centred digital transformation.